Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a national …

C Di Somma, E Scarano, G de Alteriis, L Barrea… - Journal of …, 2021 - Springer
Purpose Gender differences in patients diagnosed with non-functioning Pituitary Adenomas
(NFPA) in a National Referral Center for Pituitary Tumors at the Federico II University of …

[HTML][HTML] Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas

D Modena, ML Moras, G Sandrone, A Stevenazzi… - Cancers, 2023 - mdpi.com
Simple Summary Therapy for nonfunctioning pituitary adenomas (NFPAs) is a significant
unmet medical need since these adenomas are frequently invasive, are difficult to resect …

[HTML][HTML] Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics

X Bao, G Wang, S Yu, J Sun, L He, H Zhao, Y Ma… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: The invasive behavior of non-functioning pituitary neuroendocrine tumors (NF-
PitNEts) presents obstacles for complete surgical resection and is indicative of poor …

[HTML][HTML] Transcriptomic profiles of normal pituitary cells and pituitary neuroendocrine tumor cells

JY Oh, RC Osorio, J Jung, L Carrete, N Choudhary… - Cancers, 2022 - mdpi.com
Simple Summary The molecular pathogenesis of pituitary neuroendocrine tumors (PitNETs)
involves the interplay of many genes and transcription factors in the setting of a diverse …

Digital image analysis allows objective stratification of patients with silent PIT1‐lineage pituitary neuroendocrine tumors

J Zhao, C Ji, H Cheng, Z Ye, B Yao… - The Journal of …, 2023 - Wiley Online Library
Studies describing the clinical presentation and prognosis of patients with silent PIT1
(pituitary specific transcription factor)‐lineage pituitary neuroendocrine tumors (PitNETs) are …

Refractory nonfunctioning pituitary adenomas

T Kolitz, Y Greenman - Pituitary, 2023 - Springer
Non-functioning pituitary adenomas (NFPAs) comprise silent tumors of different pituitary
lineages that tend to escape early detection and present as invasive macroadenomas with …

[HTML][HTML] Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas

N Akbari, M Ghorbani, V Salimi… - BMC Endocrine …, 2020 - Springer
Background Pituitary adenomas as multifactorial intracranial neoplasms impose a massive
burden of morbidity on patients and characterizing the molecular mechanism underlying …

Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays

A Banerjee, A Ray, A Barpanda, A Dash… - PROTEOMICS …, 2022 - Wiley Online Library
Purpose To identify the specific diagnostic biomarkers related to pituitary adenomas (PAs),
we performed serological antibody profiles for three types of PAs, namely Acromegaly …

Recent advances in proteomics and its implications in pituitary endocrine disorders

A Banerjee, A Goel, A Shah, S Srivastava - Biochimica et Biophysica Acta …, 2021 - Elsevier
Pituitary adenoma is considered as one of the most frequent intracranial tumors having
salient impact on human health such as mass effects, hypopituitarism and visual defects etc …

[HTML][HTML] Intratumoural spatial distribution of S100B+ folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours

MD Ilie, A Vasiljevic, M Chanal, N Gadot… - Acta Neuropathologica …, 2022 - Springer
Folliculostellate cells are S100B-expressing cells with numerous functions in the normal
anterior pituitary. These cells have also been identified in pituitary neuroendocrine tumours …